healthcare-in-europe.com
Crohn's disease: Mesenteric-based surgery shows promise
The study suggests a surgical change—removing the mesentery during Crohn’s operations—may significantly reduce early recurrence in the intestinal lining, which could mean fewer repeat surgeries and hospital readmissions for people with Crohn’s disease.
Adults with Crohn’s disease considering or facing surgery, colorectal surgeons and surgical teams, IBD clinicians, and researchers studying surgical outcomes or mesenteric biology.
What To Know
A new randomized trial reported in Gastroenterology and led by investigators including Professor J Calvin Coffey validates a mesentery-removal surgical technique developed at the University of Limerick.
The trial compared conventional surgery with an approach that includes removal of the mesentery and found lower rates of endoscopic recurrence (reported in the article as a reduction from ~46% to ~23%) and reduced severity of relapse when the mesentery was removed.
The article emphasizes that removing the mesentery—reclassified as an organ by the Coffey group—was previously uncommon because of technical challenges, but that the new technique may decrease readmissions, repeat medications, and reoperations.
The piece frames the findings as supportive evidence that mesentery removal during Crohn’s surgery could become standard practice pending broader adoption. This summary reflects the source article from Healthcare-in-Europe, which cites the University of Limerick and the published trial in Gastroenterology.
It does not attempt to provide medical advice or to replace reading the original study for details about methods, patient selection, or longer-term outcomes.
This article reports on a randomized control trial validating a surgical technique; readers should consult the original Gastroenterology paper for full methodology, patient selection, and long-term outcomes. Surgical techniques can be operator-dependent and may not be immediately available at all centers.
